Delivery Order SPE2DB22D2006-SPE2DB25FW2RA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Synthroid 50 MCG tablets (1,000-unit quantity) valued at $1,355.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms at a ceiling value of $2,134.25. This is a firm fixed-price delivery order with no set-aside designation, completed by July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $6,931.37 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 micrograms. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.21 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 150 micrograms on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded competitively. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Synthroid 175 mcg tablets (1,000 count) on September 19, 2025, with a ceiling value of $1,893.14 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets (1,000 count) on July 22, 2025, with a ceiling value of $1,090.43. The contract employs firm fixed price pricing and is scheduled for ultimate completion by July 23, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,478.35, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,213.91 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 175 mcg on September 10, 2025, with completion expected by September 11, 2025. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Synthroid is a synthetic thyroid hormone medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 1,000 tablets of Synthroid 150 micrograms with a ceiling value of $1,575.33. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is due for ultimate completion on September 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2RADelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $50,535.07 delivery order on July 18, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. Performance will be completed by July 21, 2025, with fulfillment occurring at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as the primary vehicle for global pharmaceutical support to military healthcare systems worldwide. The IDC encompasses a comprehensive range of pharmaceutical products, medical supplies, and specialty medications to support Defense Health Agency operations and other federal healthcare customers. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts and has demonstrated capability to meet competitive procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.5k | 7/18/25 |